Actively Recruiting

Phase 4
Age: 18Years - 40Years
FEMALE
ID07474194

Comparative Study of Preoperative Clindamycin Vaginal Cream Versus Vaginal Cleansing With Povidone-iodine on Postoperative Infections After Cesarean Section

Led by Beni-Suef University · Updated on 2026-03-16

150

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This trial evaluates the effects of preoperative use of clindamycin vaginal cream compared to vaginal cleansing with a 10% povidone-iodine solution on infections after cesarean section. It focuses on postpartum infectious complications, particularly surgical site infections, in women undergoing elective cesarean sections. The study is a randomized, single-blind phase 4 trial sponsored by Beni-Suef University, aiming to improve infection control methods for this group. Participants are randomly assigned to one of three groups: a control group receiving standard prophylactic antibiotics only, a group using clindamycin vaginal cream applied nightly for three nights before surgery, or a group receiving vaginal cleansing with povidone-iodine solution just before skin incision. All participants receive standard spinal anesthesia, catheterization, antiseptic skin preparation, and postoperative antibiotics according to hospital protocols. Education on wound care and infection symptoms is provided to all. During the study, participants are monitored for signs of infection up to three weeks after surgery. Evaluations include clinical assessments of the surgical site and symptoms such as fever, discharge, pain, swelling, redness, or wound opening. The primary outcome is the occurrence of wound infection within three weeks. Participants receive routine postoperative care and are advised to seek hospital care if infection symptoms appear. The total participation period includes the preoperative treatment and the three-week follow-up.

CONDITIONS

Brief Title

Preoperative Clindamycin Vaginal Cream Versus Vaginal Cleansing With Povidone-iodine on Postoperative Infections After Cesarean Section

Who Can Participate

Age: 18Years - 40Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female participants with singleton pregnancies scheduled for elective cesarean sections at term between 37 and 40 weeks of gestation
  • Participants aged 18 to 40 years
  • Body mass index (BMI) between 18 and 30 kg/m2
  • Free from any medical disorders
Not Eligible

You will not qualify if you...

  • Urgent or emergent cesarean section cases
  • Abnormal vaginal secretions such as bad smelling yellowish discharge, whitish cheesy discharge with itching, or bloody discharge
  • Medical disorders including pre-gestational diabetes, anemia, hypertension, preeclampsia, or immunosuppression
  • Skin infection near the surgical site
  • Allergy to topical povidone-iodine or clindamycin
  • Fever, history of premature rupture of membranes, or placenta previa
  • Patients lost during follow-up

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 3 nights before cesarean section and surgery day

Participants receive either clindamycin vaginal cream each night for 3 nights before cesarean section, vaginal preparation with povidone-iodine solution before skin incision, or prophylactic antibiotics according to hospital protocol during surgery.

1 to 4 visits including preoperative and surgery day

Post-operative Follow-up

Duration - Up to 3 weeks after cesarean section

Participants receive routine postoperative care and are advised to return to the hospital if symptoms of infection develop. Antibiotics are given for 5 days after discharge.

Approximately 1 follow-up visit and additional visits if symptoms occur

Trial Site Locations

Total: 1 location

1

Beni suef university

Banī Suwayf, Egypt

Actively Recruiting

Loading map...

Research Team

S

Sara Abdallah Salem, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

3

Similar Trials

Machine Learning Model-Based Risk Stratification to Reduce S...

Surgical Site Infection (SSI)

Actively Recruiting

1 location

Intracuticular Suture Alone Compared to Intracuticular Sutur...

Surgical Site Infection (SSI)

Actively Recruiting

1 location

Subcutaneous Suture Versus No Subcutaneous Suture for Abdomi...

Surgical Site Infection (SSI)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here